Table 1 Dosimetric parameters for the OARs included in the SCR estimation for the patients included in the analysis
| Â | FB | DIBH | ||||
|---|---|---|---|---|---|---|
Group 1 | Group 2 | Group 2 | ||||
PT | Tangential 3D-CRT | PT | VMAT | PT | VMAT | |
Average dose (Gy) | ||||||
 Ipsilateral lung | 5.9 ± 2.1 | 11.5 ± 1.1 | 8.4 ± 0.3 | 16.4 ± 1.6 | 7.4 ± 0.8 | 14.6 ± 0.9 |
 Contralateral lung | 0.08 ± 0.10 | 0.6 ± 0.1 | 0.3 ± 0.1 | 7.3 ± 0.4 | 0.15 ± 0.02 | 6.2 ± 0.3 |
 Contralateral breast | 0.08 ± 0.03 | 0.9 ± 0.1 | 0.09 ± 0.02 | 4.7 ± 0.3 | 0.07 ± 0.01 | 4.8 ± 0.3 |